Coronavirus jabs injected into children as young as six despite secret blood-clot fears
Government advisers raised serious concerns about potentially deadly consequences
TL;DR
- Confidential government documents reveal advisors warned of serious blood clot risks from the AstraZeneca vaccine in children.
- The trial continued to give the vaccine to children aged six and up, despite these warnings and European countries suspending the vaccine.
- Advisors questioned the ethical justification for the trial, noting the "remote" individual benefit to children and their low risk of severe Covid-19.
- Concerns were raised about the ability to treat the rare but deadly condition, vaccine-induced immune thrombotic thrombocytopenia (VITT).
- Despite safety concerns and some advisors declaring links to AstraZeneca, the trial resumed with additional safeguards.
- The AstraZeneca vaccine was never introduced into Britain's routine childhood Covid vaccination program.
- Experts have criticized the trial's ethical basis, stating there was no direct benefit for children and the risk of severe illness from Covid-19 was extremely low.